Reduction-hypersensitive podophyllotoxin prodrug self-assembled nanoparticles for cancer treatment

HIGHLIGHTS

  • who: Xinhui Wang and collaborators from the Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, China have published the research work: Reduction-Hypersensitive Podophyllotoxin Prodrug Self-Assembled Nanoparticles for Cancer Treatment, in the Journal: Pharmaceutics 2023, 784 of /2023/
  • what: Three novel Fmoc-PPT prodrugs were designed by utilizing different lengths of disulfide bonds.

SUMMARY

    Only using the nano delivery strategy to deliver highly toxic chemotherapeutic drugs may cause more serious damage to normal organs and tissues due to the prolonged retention time in_vivo. The three prodrug NPs . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?